Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: DyNeuMo-1

UCL begins first UK deep brain stimulation study for children with rare epilepsy

UCL begins first UK deep brain stimulation study for children with rare epilepsy
p p Read More

Lennox-Gastaut syndrome affects up to 5% of children living with paediatric epilepsy

June 27, 2024 Amber Therapeutics, deep brain stimulation, DyNeuMo-1, epilepsy, Great Ormond Street Hospital, King’s College London, Lennox-Gastaut Syndrome, News, University College London, university of oxford
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy